drugset / Trial / NCT02180737

Dexmedetomidine for Sedation During Radiological Interventional Procedures

NCT02180737 ↗

Phase 4 Completed 40 enrolled National Cancer Institute, Egypt
NaSingle-groupOpen-labelTreatment

Summary

Evaluation of the role of dexmedetomidine as a sole agent in sedating patients undergoing interventional radiological procedures and measuring its different outcome variables.

Timeline

Start
2014-01
Primary completion
2014-12
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified — —

Indications

No indication recorded.